Publication | Open Access
Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: a randomised trial
62
Citations
22
References
2012
Year
IDegAsp provided comparable overall glycaemic control to BIAsp 30 with a significantly lower rate of hypoglycaemia.
| Year | Citations | |
|---|---|---|
Page 1
Page 1